The main challenge of the ChARLI program is to assess the clinical burden of severe neonatal and childhood bacterial infections in low-income countries,in particular those caused by antibiotic resistant bacteria. This program will address both healthcare associated, as well as community acquired infections. Beside its main challenge, the ChARLI program will also allow the assessment of the economic burden of these infections, the improvement of their medical care and then ultimately help to set public health interventions and guide public health measures necessary to combat bacterial infections and bacterial resistance in children. It will also lead to set up more basic research investigation to better understand how pathogenic and epidemic may be the resistant clones in these countries and to experiment innovative strategies devoted to prevent these infections. In order to achieve these objectives, an international paediatric cohort will be created, and monitored a platform. This will be done first within the Institut Pasteur International Network (IPIN) and possibly extended in some others low income countries where the IPIN has no center. This constituted initiative will represent the first international pediatric program of its size to be located in low-income countries and specifically focusing severe bacterial infections and bacterial resistance to antibiotics
Study Type
OBSERVATIONAL
Enrollment
1,000
institut pasteur in Madagascar
Antananarivo, Madagascar
RECRUITINGIncidence of infections with bacteria resistant to antibiotics in neonates and young children (up to 18 months of age).
Time frame: 27 months
Bacterial aetiology of neonatal infection in low income countries and its resistance
Time frame: 27 months
Identification of factors responsible of the dissemination and transmission of multiresistant resistant bacteria in low incomes countries
Time frame: 27 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.